• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

4

CATEGORIES

  • 3
  • 1

PRICE

1
1
2
4

PUBLISHED

1
1
1
4

PRODUCT TYPE

4

Search "Generic Drug Product Development. Specialty Dosage Forms. Drugs and the Pharmaceutical Sciences" returned 4 results.

PRODUCT TITLE
CNS Therapeutics - Global Strategic Business Report CNS Therapeutics - Global Strategic Business Report - Product Thumbnail Image

CNS Therapeutics - Global Strategic Business Report

This report analyzes the worldwide markets for CNS Therapeutics in US$ Million by the following Product Groups: Anti-Alzheimers, Anti-Parkinsons, Anti-Epilepsy, Pain Management (includes Migraine, Nociceptive...

February 2013
FROM
The Top 40 Developers Of Inhaled Pharmaceuticals Worldwide The Top 40 Developers Of Inhaled Pharmaceuticals Worldwide - Product Thumbnail Image

The Top 40 Developers Of Inhaled Pharmaceuticals Worldwide

Inhaled therapies have been used since ancient times and may have had their origins with the smoking of datura preparations in India 4,000 years ago Inhalation became a mainstay of respiratory care...

October 2009
FROM
Delivering New Biopharmaceutical Therapies: Challenges & Opportunities Delivering New Biopharmaceutical Therapies: Challenges & Opportunities - Product Thumbnail Image

Delivering New Biopharmaceutical Therapies: Challenges & Opportunities

“Over the last decade, biotech antibodies have provided some of the biggest breakthroughs in medicine The list includes Avastin, Herceptin, Rituxan and Erbitux for cancer and Enbrel, Humira, and Remicade...

March 2009
Moderate to Severe Pain: Novel Abuse Deterrent Formulation Technologies and Emergence of Novel Mechanism in the Management of Pain Moderate to Severe Pain: Novel Abuse Deterrent Formulation Technologies and Emergence of Novel Mechanism in the Management of Pain  - Product Thumbnail Image

Moderate to Severe Pain: Novel Abuse Deterrent Formulation Technologies and Emergence of Novel Mechanism in the Management of Pain

Pain is the leading cause of disability in the US, affecting more than cancer, diabetes and heart disease combined. Current analgesics for persistent pain are relatively ineffective, are associated...

January 2015
FROM
Loading Indicator

Our Clients

Abbott Laboratories Ltd. Ford Motor Company Honeywell International, Inc. Nike, Inc. Deloitte LLP. IMAX Corporation